An Alternative Splice Form of Mdm2 Induces p53-independent Cell Growth and Tumorigenesis
Open Access
- 1 February 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (6), 4877-4886
- https://doi.org/10.1074/jbc.m305966200
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- NF-κB, chemokine gene transcription and tumour growthNature Reviews Immunology, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiationOncogene, 2000
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Development and malignant progression of astrocytomas in GFAP-v-src transgenic miceOncogene, 1997
- GFAP Transgenic MiceMethods, 1996
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992